Comparisons between dipeptidyl peptidase-4 inhibitors and other classes of hypoglycemic drugs using two distinct biomarkers of pancreatic beta-cell function: A meta-analysis

BACKGROUND AND OBJECTIVE: Dipeptidyl peptidase-4 (DPP-4) inhibitors have been suggested to have pancreatic beta-cell preserving effect according to studies using homeostatic model of assessment for beta-cell function (HOMA-β). However, whether HOMA-β is a suitable biomarker for comparisons between h...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Masahiro, Shibasaki, Misa, Echizen, Hirotoshi, Kushiyama, Akifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380634/
https://www.ncbi.nlm.nih.gov/pubmed/32706828
http://dx.doi.org/10.1371/journal.pone.0236603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380634/
https://www.ncbi.nlm.nih.gov/pubmed/32706828
http://dx.doi.org/10.1371/journal.pone.0236603

Ejemplares similares